Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · USD
$2.07
-0.02 (-1.0%)· Recorded snapshot
Coverage state: Market snapshot only — no published research
Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.
On-demand research
Generate the first SER analysis
Start the full research workflow when this ticker is ready in our data system.
| Market cap | 31M | |
|---|---|---|
| Revenue (ttm) | 130K | |
| Net income (ttm) | -21.6M | |
| EPS (ttm) | -$2.00 | |
| Shares out | 15M | |
| Volume | 44,323 | |
| Beta | 0.03 | |
| Price target | $9.50 | +358.9% |
Market data
Price
Recent price action with selectable time range.
Financial snapshot
- Revenue (ttm)
- 130K
- Net income (ttm)
- -21.6M
- EPS (ttm)
- -$2.00
- Market cap
- 31M
Fair-value bridge
- Current price
- $2.07
Analyst consensus
Recommendation
Strong Buy
Price target
$9.50
+358.9%
In the news
Latest news · SER
Recent company headlines from major financial publishers.
Valuation
- Market cap
- 31M
- P/S
- 238.8x
- P/B
- 2.4x
Profitability
- Operating margin
- -18803.1%
- ROE
- -221.9%
- ROA
- -89.8%
- ROIC
- -133.2%
Balance sheet
- Debt / equity
- 0.19
- Current ratio
- 4.18
- Quick ratio
- 3.87
Trading
- Beta
- 0.03
- Volume
- 44,323
- Dividend yield
- 0.0%